More
Guided Solutions - Connecting Talent With Innovation/div>

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the standard of care (SoC). The Irish device company’s ReActiv8 Restorative Neurostimulation...

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the...

GT Medical raises $37m to advance bioresorbable radiation tile

GT Medical Technologies announced it completed a $37 million first close of a Series D financing round. The funds support the completion of clinical...

FDA grants clearance to icotec’s BlackArmor implants to treat spinal infection

The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal...

CardioFocus has positive pulsed field ablation data for its Centauri system

CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...
[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the...

CardioFocus has positive pulsed field ablation data for its Centauri system

CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...

NanoVibronix “achieves goals” of US trial pilot phase with UroShield

NanoVibronix has completed the first phase of a randomised control trial with UroShield, the company’s disposable ultrasound device designed to prevent catheter-associated urinary tract...

CathWorks completes enrolment in CAD treatment system trial

CathWorks completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary artery disease (CAD). The Advancing Cath...
[td_block_social_counter twitter=”GuidedSolutions” style=”style1″ tdc_css=”eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjUwIiwiZGlzcGxheSI6IiJ9LCJsYW5kc2NhcGUiOnsibWFyZ2luLWJvdHRvbSI6IjQwIiwiZGlzcGxheSI6IiJ9LCJsYW5kc2NhcGVfbWF4X3dpZHRoIjoxMTQwLCJsYW5kc2NhcGVfbWluX3dpZHRoIjoxMDE5LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3NjgsInBob25lIjp7Im1hcmdpbi1ib3R0b20iOiIzNSIsImRpc3BsYXkiOiIifSwicGhvbmVfbWF4X3dpZHRoIjo3Njd9″ manual_count_twitter=”1663″ open_in_new_window=”y”]

Innovation

Regulatory Approvals

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the...

GT Medical raises $37m to advance bioresorbable radiation tile

GT Medical Technologies announced it completed a $37 million first close of a Series D financing round. The funds support the completion of clinical...

FDA grants clearance to icotec’s BlackArmor implants to treat spinal infection

The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal...

CardioFocus has positive pulsed field ablation data for its Centauri system

CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...

M&A

Archives

Latest articles